Thursday, May 24, 2012
"The source for European pharmaceutical biotechnology news..."
Sponsors
Platinum Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Drug Discovery
Brave new world
NGP catches up with Invitrogen CEO Greg Lucier to discuss the firm?s strategies for growth, its core competencies and why a healthy European pharmaceuticals market is important for the well-being of the industry.
No Comments
The experts? forum
New screening technologies are allowing the incorporation of ADME/Tox profiling into the earliest phases of the discovery process ? which in turn is facilitating better decision-making in pharmaceutical R&D.
No Comments
Crisis? What crisis?
As the drug development pipeline dries up, Robert McKinnon, Ken Worzel, Greg Rotz and Harriet Williams of Marakon Associates offer a fresh diagnosis of Big Pharma?s R&D productivity crunch.
No Comments
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.